It will depress demand as well (not just supply). It seems to be even more highly transmissible than Delta (only Delta Airlines may be relieved that thereās finally another strain unrelated to Delta ).
The stock market being so down has me looking for bargains TBH.
I expect the world will adjust to Covid and now that we have relatively quick vaccine āadjustmentā options I guess Iām an optimist.
My bigger worry is our trip to USVI this February. I really like stocking up on Vitamin D in Feb and donāt know how or if this variant will affect travel.
My concern is also more about the effect on travel, particularly for my D who hopes to participate in two study abroad experiences this spring/summer. Iām not as concerned about my personal āfunā travel, but I want her to enjoy every bit of her college experience and that includes study abroad opportunities.
Tough call, in my view, as to whether or not this is a buying opportunity. Might buy both calls & puts on an index fund as there might be significant movements in both directions (on different days, of course).
Regardless, not a good time to be in stocks of cruise ship companies, while Moderna looks like a reasonable buy.
Mushrooms are likely the best bet for future health from what Iāve been reading. Google ergothioneine⦠Mushrooms are the main source and the studies Iāve been reading about it make me glad Iām a mushroom lover. Vit D I like to restock my body from sunshine in Feb.
We did well with todayās buys. Time will tell next week and beyond if my thoughts were really worth it or not. For today Iām content having been able to get some options Iād been looking at on my āBlack Fridayā sale.
Cruise lines and similar werenāt on my āwant to buy listā anyway TBH.
If Plan A happens weāre on the road Monday so I wonāt be following the market at all to buy or cash out.
What I bought I plan to keep for a bit and if some of my buy orders had hit their target earlier this week Iād have paid more for them - hence - content with a sale even if I didnāt hit the bottom of the dip. I donāt need to cash out by end of year. Omicron might cause some problems, but I donāt think they will be lengthy ones at this point.
We tend to do a mix of dividend stocks and shoot for the moon medical stocks (having made out very well on Longeveron for instance). Both (usually) require some time to do their thing.